Is hydroxyzine (Vistaril) appropriate for treating restless legs syndrome without affecting blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydroxyzine (Vistaril) Should NOT Be Used for Restless Legs Syndrome

Do not use hydroxyzine (Vistaril) for restless legs syndrome—it can actually worsen RLS symptoms and is specifically contraindicated in this condition. 1

Why Hydroxyzine Is Harmful in RLS

Hydroxyzine blocks central dopamine transmission, which directly exacerbates RLS symptoms. Case reports document severe perioperative complications in RLS patients who received hydroxyzine, including:

  • Inability to remain still with involuntary leg jerks
  • Generalized pain followed by suicidal ideation
  • Severe agitation and akathisia
  • Acute exacerbation requiring emergency intervention 1

The mechanism is clear: RLS involves dopaminergic dysfunction, and antihistamines like hydroxyzine that antagonize dopamine worsen the underlying pathophysiology.

Regarding Blood Pressure Concerns

While you're seeking treatments that don't affect blood pressure, the 2025 American Academy of Sleep Medicine guidelines provide excellent options that are both effective and cardiovascularly neutral:

First-Line Treatments (Strong Recommendations)

1. Gabapentinoids - These are your best options:

  • Gabapentin enacarbil (strong recommendation) 2
  • Gabapentin (strong recommendation) 2
  • Pregabalin (strong recommendation) 2

These medications do not significantly affect blood pressure and are now considered the primary pharmacologic therapy for RLS 3, 4. They work through α2δ calcium channel modulation rather than cardiovascular mechanisms.

2. Intravenous Iron Therapy (if appropriate iron parameters):

  • IV ferric carboxymaltose (strong recommendation) 2
  • Check ferritin and transferrin saturation first
  • Supplement if ferritin ≤75 ng/mL or transferrin saturation <20% 2
  • Iron therapy has minimal cardiovascular effects

Additional Options (Conditional Recommendations)

  • Oral ferrous sulfate (conditional recommendation) - if iron deficient 2
  • Dipyridamole (conditional recommendation) 2

Critical Pitfalls to Avoid

Medications that WORSEN RLS and must be avoided:

  • Hydroxyzine and other antihistamines with central dopamine-blocking effects 1
  • Droperidol
  • Any antidopaminergic medications
  • Many antidepressants (particularly serotonergic agents) 2

Dopamine agonists are no longer first-line due to augmentation risk (worsening of symptoms over time), though they may have short-term benefits 2, 3, 4.

Practical Treatment Algorithm

  1. Check iron studies (ferritin, transferrin saturation) - draw fasting, avoid iron-containing supplements/foods 24 hours prior 2

  2. If iron deficient: Start oral ferrous sulfate OR IV iron therapy depending on severity

  3. For pharmacologic treatment: Start a gabapentinoid:

    • Gabapentin 300-900mg at bedtime, or
    • Pregabalin 75-150mg at bedtime, or
    • Gabapentin enacarbil 600mg in evening
  4. Avoid all dopamine-blocking agents, including hydroxyzine

These gabapentinoid medications are cardiovascularly neutral and represent the modern standard of care, having replaced dopamine agonists as first-line therapy due to superior long-term safety profiles 3, 4.

References

Guideline

treatment of restless legs syndrome and periodic limb movement disorder: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025

Research

Restless Legs Syndrome and Periodic Limb Movements.

Continuum (Minneapolis, Minn.), 2026

Research

The evolving treatment landscape of restless legs syndrome.

Therapeutic advances in neurological disorders, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.